IEQ Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
IEQ Capital's AZN Position: Q2 2026 in Review
IEQ Capital reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $718K and leaving 32,151 shares worth $6.1M. The position accounts for 0.03% of the portfolio, ranked #452.
IEQ Capital first reported a position in AZN in Q4 2019 and has held it in 21 quarters since. The position peaked at $7.09M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- IEQ Capital held 32,151 shares of AstraZeneca worth $6.1M as of Q2 2026.
- IEQ Capital sold 3,819 AstraZeneca shares in Q2 2026, an estimated $718K.
- AstraZeneca made up 0.03% of IEQ Capital's portfolio in Q2 2026, its #452 holding.
- IEQ Capital first reported a position in AstraZeneca in Q4 2019 and has held it in 21 quarters since.
- IEQ Capital's AstraZeneca position peaked at $7.09M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.